ĐÁNH GIÁ KẾT QUẢ ĐIỀU TRỊ U PHÌ ĐẠI LÀNH TÍNH TUYẾN TIỀN LIỆT BẰNG PHẪU THUẬT NỘI SOI QUA ĐƯỜNG NIỆU ĐẠO TẠI BỆNH VIỆN BƯU ĐIỆN

Abstract

Objective: The aim of this study is to evaluate the treatment result of benign prostatic hyperplasia by transurethral resection of the prostate at the Hospital of Post and Telecommunications. Subject and method: This is a descriptive study of 105 patients with Benign prostatic hyperplasia treated by transurethral resection of the prostate at the Hospital of Post and Telecommunications from period of June 2022 to June 2023. Result: All pre-operative patients have been through lower urinary tract symptoms; by which, there was 17,1% of 105 patients got urine retention. The average prostate weight was 62,7 ± 10,2g and among that 68,5% cases had the weight over 50g. After surgery, there was only 12,4% lower urinary tract symptoms remained and the average prostate weight reduced to 23,3 ± 8,4g with 84,8% cases < 30g. Bleeding complication during surgery was 4,8% - 5 patients. There was 7,7% post-surgery complication cases which were: 2 patients got bleeding accounting for 1,9%, 3 patients got urinary retention after urinary withdrawal (2,9%) and 3 patients got urine tract infection (2,9%). Before the surgery, the average IPSS  was 27,3 ± 3,9 and mainly was severe cases of  90,5%. There was 71,4% cases with high QoL, average score of 5,2 ± 0,8. After surgery: the average IPSS was 5,6 ± 2,4 mostly was mild cases (87,6%) and  the average QoL reduced to 1,6 ± 0,7. The overall results after surgery were 87,6%; 12,4% for good and average respectively; no any cases with bad result. Conclusion: Transurethral resection of the prostate for benign prostatic hypertrophy is a safe and effective method to improve patient quality of life.